Saturday 17 October 2026 Export EBS’s income statement to Excel — free account

Emergent Biosolutions Inc.

EBS Healthcare Drug Manufacturers Specialty & Generic

Emergent Biosolutions Inc.’s revenue for fiscal 2025 (year ended December 2025) was $742.9 million, down 28.8% from fiscal 2024. In the quarter to June 2026, revenue grew 66.3%, EPS fell 1,486.4%, free cash flow fell 47.7% and total debt fell 12.9%, each against the same quarter a year earlier.

6.38 0.80 −11.14%

Follow EBS

Alert me

Market cap: $368.1M
P/E: 0.0×
Fwd P/E: −26.5×
Dividend yield: —
F-score: 6/9
Altman Z: 1.63
Beneish M: −3.56
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	6.26	13.01	0.00	0.00
P/S ratio Full definition →		0.59	0.89	0.64	0.56
P/FCF ratio Full definition →		11.76	3.39	3.18	5.02
P/Operating CF Full definition →		(204.01)	8.51	(12.74)	7.71
P/B ratio Full definition →		0.81	1.27	0.82	1.27
Price to Tangible BV Full definition →		3.62	7.68	8.17	5.43
EV/Sales Full definition →		1.12	1.38	1.25	1.13
EV/EBITDA Full definition →		3.91	4.98	5.15	23.69
EV/Operating CF Full definition →		67.99	6.01	5.70	8.95
EV/FCF Full definition →		22.15	5.26	6.23	10.15
Quick Ratio Full definition →		2.92	2.22	1.90	2.69
Current Ratio Full definition →		5.76	5.01	4.29	5.42
Net Debt/EBITDA Full definition →		4.04	(201.67)	11.51	(4.43)
Debt/Assets Full definition →		45.39%	43.39%	43.44%	52.10%
Debt/Equity Full definition →		1.14	1.09	1.10	1.70
Asset Turnover Full definition →		0.54	0.55	0.49	0.61
Operating CF/Net income Full definition →		(0.04)	(1.42)	(4.97)	(0.31)
Capex/Depreciation Full definition →		(0.13)	(0.15)	(0.09)	(0.07)
Interest Coverage Full definition →		5.03	(1.90)	0.95	(12.51)
Research and Development Expense of Revenue Full definition →		5.84%	8.14%	6.73%	3.93%
Selling, General and Administrative Expense of Revenue Full definition →		16.83%	34.36%	29.85%	19.04%
Intangible Assets out of Total Assets Full definition →		0.31	0.33	0.36	0.23
Share Based Compensation of Revenue Full definition →		2.08%	3.56%	1.22%	2.94%
Graham Net Nets Full definition →		(0.20)	(0.20)	(0.37)	(0.25)
Graham Number Full definition →		18.64	14.45	0.00	0.00
Earnings Yield Full definition →		15.99%	7.69%	(2.05%)	(41.05%)
Free Cash Flow Yield Full definition →		8.50%	29.49%	31.46%	19.91%
Revenue per Share Full definition →		4.34	2.78	3.01	4.54
Operating CF per Share Full definition →		(0.04)	1.45	(0.65)	1.09
Capex per Share Full definition →		(0.06)	(0.07)	(0.05)	(0.04)
Free Cash Flow per Share Full definition →		(0.11)	1.38	(0.70)	1.05
Cash per Share Full definition →		4.68	3.91	3.11	2.73
Shareholders Equity per Share Full definition →		10.95	9.77	10.08	6.62
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		10.95	9.77	10.08	6.62
Free Cash Flow Full definition →		(5.70)	73.80	(36.20)	54.20
Working Capital Full definition →		650.40	530.30	488.90	543.20
Capital Expenditures Full definition →		(3.40)	(3.90)	(2.40)	(1.90)
Net Current Asset Value Full definition →		(91.60)	(133.50)	(159.70)	(109.40)
EV/EBIT Full definition →		7.46	10.24	13.90	0.00
Capex to Sales Full definition →		0.01	0.03	0.02	0.01
Price to Operating Income Full definition →		3.96	6.61	7.10	0.00
Other line items
Average Receivables Full definition →		135.40	119.35	162.65	134.90
Average Payables Full definition →		69.75	58.25	48.80	56.95
Average Inventory Full definition →		339.50	327.55	320.80	321.10
Average Assets Full definition →		1,469.40	1,354.15	1,373.25	1,266.95
Average Common Equity Full definition →		545.45	502.70	537.90	438.80

Fold the line items

Columns are period end dates

Stockrow Weekly